DocDollars

Bayer Healthcare Pharmaceuticals Inc.

NJ · United States · Reporting entity ID 100000005467

Total reported 2019–2025
$402.9M
#43 of 2,960 reporting companies — 0.5% of all reported industry payments
$79.2M in general payments across 858,033 records, plus $323.7M in research funding across 62,940 records.

How it breaks down

General payments $79,187,740
Research funding $323,676,658

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Bayer Healthcare Pharmaceuticals Inc. reported $402.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #43 of 2,960 reporting companies. 80% of that was research funding and 20% general payments such as consulting, speaking, food and travel. 858,033 general payment records and 62,940 research records were filed.

Common questions about Bayer Healthcare Pharmaceuticals Inc.

How much has Bayer Healthcare Pharmaceuticals Inc. paid US doctors?

Bayer Healthcare Pharmaceuticals Inc. reported $402,864,397 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $79,187,740 in general payments, $323,676,658 in research funding.

How does Bayer Healthcare Pharmaceuticals Inc. rank among drug and device companies?

It ranks #43 of 2,960 reporting entities by total reported value, about 0.5% of all industry payments in the dataset.

Does a payment from Bayer Healthcare Pharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.